Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2018

Mar 2, 2018

31802_dirs_2018-03-02_49fb66e7-cb6c-48b8-9fff-fee4910d675a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2018-03-01

Reporting Person: Drake Scott William (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-01 Common Stock P 11000 $17.64 Acquired 16805 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $17.36 to $17.91 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.